Mumbai, June 24 -- The Board ofAstec LifeSciences at its meeting held on 24 June 2025 has approved the issue of fully paid-up equity shares of the company of face value of Rs. 10/- eachfor an amount not exceeding Rs. 250 crore by way of a rights issue to the eligible equity shareholders of the company.
Published by HT Digital Content Services with permission from Capital Market....
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.